| Auditory and speech performance after cochlear implantation
Categories of auditory performance (CAP) and speech intelligibility rating (SIR) scores were assessed at 3 months, 6 months, 1 year, 3 years and 5 years post-implant, whereas speech perception tests were performed at 3 years post-implant. 7 The duration of CI use in
Keypoints
• ANSD patients with OTOF mutations exhibit excellent CI outcomes comparable to patients with cochlear SNHI with other genetic causes.
• ANSD patients with OTOF mutations do not experience spontaneous recovery in hearing thresholds or ABR with age.
• Cochlear implantation should be performed in ANSD patients with OTOF mutations whenever indicated without unnecessary delay.
• Genetic testing is a useful tool to clarify aetiology in patients with ANSD.
• Genetic testing could be included in the pre-CI evaluation battery of patients with ANSD for a better prediction of the outcome. The age at cochlear implantation ranged from 1.0 to 5.6 years.
T A B L E 1 Genetic and clinical features of study participants
Early in the present study, cochlear implantation was performed on patients DE3247 and DE4496 at the age of 5. Before the operation, these patients did not experience spontaneous recovery in hearing thresholds or ABR with age. Given the stable auditory phenotypes observed preoperatively and the satisfactory CI outcomes, cochlear implantation should be performed in patients with OTOF mutations whenever indicated, without unnecessary delay.
| Comparisons with other studies
Favourable CI outcomes have been documented in a few patients with OTOF mutations ( 
| Strengths and limitations of the study
To our knowledge, this study represents the largest series in the literature documenting electrophysiological data and auditory and speech performances of cochlear implantation in ANSD patients with OTOF mutations. By cross-referring these results to those observed in patients with GJB2 or SLC26A4 mutations, we provide direct evidence that CI outcomes in ANSD patients with OTOF mutations are as favourable as those in CI recipients with a definite cochlear pathology. However, because the number of patients is limited, more cases need to be accumulated to validate our conclusion.
Some limitations of this study deserve discussion. First, ANSD is very aetiologically heterogeneous, and screening for OTOF mutations could only identify the CI candidates predicted to have good outcomes, not those with unfavourable outcomes. However, this limitation could be overcome with the availability of high-throughput DNA sequencing to address paediatric SNHI. By simultaneously screening 129 deafness genes using the massively parallel sequencing technique, our recent study demonstrated that mutations in DFNB59 and PCDH15, two genes expressed in the spiral ganglion neurons and/or brainstem auditory nuclei, were associated with unfavourable CI outcomes. 4 Second, as in most previous reports, all 10 patients with OTOF mutations in this study had stationary severe-to-profound hearing levels before surgery, and the decision to perform cochlear implantation in these patients at an earlier age is less controversial. This "early-intervention" strategy may not be applicable for patients with certain uncommon OTOF mutations related to less severe or fluctuating hearing levels. Although favourable CI outcomes have been reported in a temperature-sensitive ANSD case resulting from specific OTOF mutations, a longer period of observation of these patients may be necessary to ensure that indications for cochlear implantation are fulfilled. 
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CONFLI CT OF INTEREST
None to declare. Before surgery, all patients were subjected to comprehensive audiological examinations and imaging studies of the temporal bone, which included both high-resolution computed tomography (CT) and MRI. For all paediatric patients, genetic testing was also performed to ascertain the aetiologies. 2.4 | Intra-operative assessment of round window membrane exposure
For each ear, a standard cortical mastoidectomy and posterior tympanotomy were first performed using microscopy. After best surgical efforts to expose the round window membrane in its entirety, preserving the facial nerve, chorda tympani and posterior ear canal wall, CORRESPONDENCE: OUR EXPERIENCE
